Nicole Cain alias Dr. Panic Profit

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure identifying the biological and psychological drivers behind your panic, from gut dysbiosis and hormonal imbalance to unprocessed trauma.

identifying the biological and psychological drivers behind your panic, from gut dysbiosis and hormonal imbalance to unprocessed trauma

Supports

There is growing evidence that biological factors contribute to panic and other anxiety disorders, but the support is partial and indirect for each driver mentioned in the claim. Regarding gut dysbiosis: recent case–control work in panic disorder shows distinct gut microbial signatures, including reduced richness and alterations in taxa such as reduced butyrate‑producing bacteria and increased potentially pro‑inflammatory genera, suggesting the gut–brain axis may play a role in panic pathophysiology.^[11] Broader systematic and narrative reviews on anxiety and depression report that anxiety disorders are often associated with reduced microbial diversity, lower short‑chain‑fatty‑acid‑producing bacteria, and higher abundance of pro‑inflammatory species, supporting a link between dysbiosis and anxiety states more generally.^{[15][17][24][23]} A systematic review of probiotic supplementation for anxiety disorders finds that some randomized trials show small improvements in anxiety symptoms, indicating that modulating the microbiota can influence anxiety, although effects are modest and heterogeneous.^[6][17] Regarding hormonal and stress biology: panic disorder is consistently associated with dysregulation of the hypothalamic‑pituitary‑adrenal (HPA) axis and stress hormones. One clinical study reports negative correlations between key pro‑inflammatory cytokines (IL‑1β, IL‑12, TNF‑γ) and cortisol levels in panic disorder, linking immune and endocrine changes to the condition.^[5] Reviews on the gut–brain axis and anxiety note that chronic stress can alter the microbiome and immune signaling via HPA axis activation, which in turn affects anxiety‑related behavior.^[5][21][22] This supports the idea that stress‑hormone and inflammatory dysregulation are biological drivers for anxiety and panic, even if specific “hormonal imbalance” labels are not always used. Regarding trauma and psychological drivers: epidemiologic work shows that individuals with panic disorder have high rates of lifetime traumatic experiences, including childhood sexual abuse, and that trauma may act as a risk factor for panic disorder and for comorbid panic disorder with PTSD.^[12] Studies in PTSD populations find that comorbid panic attacks are common (around one‑third of cases) and are associated with greater symptom burden, comorbidity, and impairment, indicating an important link between trauma exposure and subsequent panic symptoms.^[25] Trauma‑focused and mindfulness‑based psychotherapies show benefit for trauma‑related symptoms, and systematic reviews of meditation for PTSD and trauma‑focused psychotherapies support the role of addressing unprocessed trauma in reducing psychological distress, indirectly supporting the idea that trauma‑related processes drive panic in at least a subset of patients.^[4][7] Taken together, the evidence supports that biological factors (including stress‑hormone and immune dysregulation and gut–brain axis changes) and psychological factors (including trauma history) can contribute to panic symptoms, aligning partially with the influencer’s emphasis on identifying biological and psychological drivers.

Contradicts

Despite emerging data, the specific claim that gut dysbiosis, generic “hormonal imbalance,” and unprocessed trauma are central or universal drivers of panic is stronger than what current evidence supports. Gut dysbiosis: most data linking microbiota and panic or anxiety are cross‑sectional associations or Mendelian‑randomization analyses, not definitive causal trials. Case–control studies in panic disorder and generalized anxiety disorder show altered microbial profiles and reduced richness, but findings across studies are heterogeneous and not yet specific enough to claim that gut dysbiosis is a primary driver of panic attacks for most patients.^{[11][13][15][18][19][20][24]} Systematic reviews emphasize that mechanisms are unclear, and that causal relationships between gut bacteria and anxiety disorders remain to be proven, noting substantial gaps and inconsistency.^{[10][17][22][23][24]} Probiotic trials show small, variable effects on anxiety, and reviews stress the need for larger, high‑quality RCTs before strong clinical claims are made.^[6][17] This contradicts any implication that correcting gut dysbiosis is a validated core treatment for panic disorder. Hormonal imbalance: while HPA axis and cortisol changes are documented in panic disorder, the evidence does not support simple, broad statements that “hormonal imbalance” in general is a main driver of panic.^[5][21] Endocrine abnormalities are heterogeneous, often modest, and not specific to panic; routine endocrine or “hormone balancing” interventions are not established first‑line treatments in guidelines for panic disorder. The influencer’s framing risks oversimplifying complex neuroendocrine findings.

In their own wordsView sourceArchived copy

“identifying the biological and psychological drivers behind your panic, from gut dysbiosis and hormonal imbalance to unprocessed trauma.”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Hormone imbalance and replacement

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure depression.

depression

Supports

High-quality evidence specifically on comprehensive naturopathic care for depression is limited, but some components of naturopathic practice (e. ^{[10][12][14][16]} g. , certain herbal medicines, lifestyle interventions, and acupuncture) have supportive data in depression or comorbid conditions. A systematic review and meta-analysis of herbal medicine for major depressive disorder found that herbal medicine alone produced depression scale improvements similar to antidepressants, and herbal medicine plus antidepressants improved both biomarkers and symptoms more than antidepressants alone, supporting a role for some plant-based treatments as adjuncts or possible alternatives in MDD when quality-controlled and used within a medical framework. ^[9] Several systematic reviews of herbal medicine report potential benefits of agents such as saffron, chamomile, lavender, and others on depression and anxiety symptoms, with generally favorable risk–benefit profiles compared with standard treatments when used appropriately. Complementary and alternative medicine guidelines (e. ^[6] g. , CANMAT and American College of Physicians) acknowledge that some CAM modalities such as exercise, light therapy, omega-3 fatty acids, and St John’s wort have evidence for mild to moderate depression and can be used as monotherapy or adjunctive therapy within an evidence-based care plan. ^[5][11] Narrative and pragmatic clinical studies of “natural therapies” or individualized herbal medicine for self-reported depression and anxiety show symptom improvements over time, suggesting that integrative approaches incorporating counseling, lifestyle change, and natural products can be acceptable and potentially helpful, although these studies are often uncontrolled or small and therefore preliminary. ^[15] Acupuncture, often used by naturopathic clinicians, has RCT data showing improvement of anxiety and depression symptoms in patients with chronic insomnia and associated changes in cortisol and serotonin, supporting its use as a nonpharmacologic adjunct in selected patients. ^[13] Overall, the evidence base supports some specific naturopathic tools (certain herbs, exercise, diet patterns like Mediterranean diet, acupuncture, and other lifestyle measures) as adjunctive treatments that can reduce depressive symptoms or improve related outcomes, particularly in mild to moderate depression.

Contradicts

There is no high-quality evidence that broad, unspecific “naturopathic doctor treatment” is equivalent or superior to guideline-recommended pharmacotherapy and psychotherapy for moderate to severe major depressive disorder; major guidelines do not recommend naturopathy as a first-line stand-alone treatment for such cases. ^{[5][6][8][10]} Modern depression guidelines emphasize structured psychotherapies (such as cognitive-behavioral therapy and interpersonal psychotherapy) and antidepressant medications as core treatments with strong evidence, and they only provide conditional or adjunctive recommendations for complementary and alternative modalities. ^[11] Evidence for naturopathic care as a system (rather than individual components) in depression is sparse, with existing studies often uncontrolled, small, pragmatic, or focused on self-reported rather than diagnostically confirmed depression, which limits confidence and generalizability. ^[14][15] Randomized trials of certain “natural” or CAM interventions show mixed or negative results; for example, some nutraceutical combinations have not performed better than placebo in MDD, highlighting that not all natural or multi-supplement approaches are effective. Homeopathy, which may be included by some naturopathic practitioners, has at least one partially double-blind RCT showing no clinically relevant difference between homeopathic remedies and placebo in depression, indicating that this commonly promoted “natural” modality does not have robust efficacy for depressive disorders. Major guidelines for depression do not list naturopathic medicine as a recommended primary treatment and warn that use of CAM alone in moderate to severe depression may delay or replace effective evidence-based care, posing risk of undertreatment, persistence or worsening of symptoms, and increased suicide risk. ^[12] Overall, the evidence contradicts any strong claim that naturopathic doctor treatment alone is a validated, first-line, comprehensive therapy for clinical depression across severity levels, especially for major depressive disorder. ^[16]

Mainstream view

The mainstream medical position is that depression, particularly major depressive disorder, should primarily be treated with evidence-based psychotherapies and/or antidepressant medications, as recommended in major clinical practice guidelines. ^{[5][6][10][12][13][16]} Complementary and alternative treatments, including selected herbal medicines, acupuncture, exercise, light therapy, omega-3 fatty acids, and some dietary interventions, may be integrated as adjuncts or, in mild cases, as monotherapies when patients prefer them and when safety and quality can be assured, but they do not replace established first-line treatments for moderate to severe depression. ^[9][11][15] Major guideline bodies consider CAM (and by extension most naturopathic interventions) as secondary options with variable evidence; they emphasize that any use of CAM should occur within a collaborative, patient-centered framework that includes monitoring, attention to drug–herb interactions, and clear communication with medical providers. Naturopathic doctors are not generally recognized in mainstream guidelines as primary providers for depression management, although individual naturopathic ^[14]

In their own wordsView sourceArchived copy

“depression”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Depression

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure bipolar disorder.

bipolar disorder

Supports

High-quality evidence for bipolar disorder focuses on conventional pharmacologic and psychosocial treatments (lithium, valproate, antipsychotics, psychotherapy, psychoeducation, adherence interventions), not on naturopathic whole-system care. Recent randomized trials show efficacy of standard agents such as long-acting injectable aripiprazole for maintenance treatment in bipolar I disorder, prolonging time to recurrence of mood episodes compared with placebo, and confirm the central role of mood stabilizers and antipsychotics in mainstream care.^[22][23] Systematic reviews and randomized trials of complementary and alternative medicine identify some nutraceuticals (e.g., omega-3 fatty acids, N-acetylcysteine, certain amino acid drinks, folate) as having modest, inconsistent benefits when used as adjuncts to standard pharmacotherapy, not as stand-alone replacements.^[6][11] Reviews on complementary and alternative medicine in bipolar disorder conclude that integrative use of selected nutrients alongside conventional mood stabilizers and antipsychotics may help bipolar depression or mania in some patients, but emphasize that these are adjunctive and evidence is limited in quality and size.^{[5][6][7][9][11]} A 2019 overview of whole-system, multimodality care reports only a small retrospective case series (n=7) of treatment-resistant bipolar patients receiving naturopathic care for more than one year, with varied outcomes including some mood stabilization and withdrawal of psychotropic medications; as an uncontrolled case series, this is very low-level evidence rather than robust support for efficacy.^[8]

Contradicts

There are no large randomized controlled trials, meta-analyses, or major psychiatric guidelines demonstrating that naturopathic doctor–led treatment alone is effective or safe as a primary therapy for bipolar disorder or as a replacement for mood stabilizers and antipsychotics.^{[5][6][7][9][11][22][23]} The single reported case series of naturopathic management of treatment-resistant bipolar disorder (n=7) is retrospective, uncontrolled, and heterogeneous, offering only anecdotal-level evidence and cannot establish causality or generalizable effectiveness.^[8] Systematic reviews of complementary and alternative therapies in bipolar disorder consistently describe the evidence base as small, methodologically limited, and inconsistent; many nutraceuticals and CAM modalities show no significant benefit over placebo or only weak effects, and are recommended, at most, as adjuncts after first-line conventional treatments rather than as core or sole treatments.^{[5][6][7][9][11]} Recent and ongoing bipolar disorder trials continue to investigate conventional pharmacologic treatments, behavioral adherence interventions, and diet-based protocols (e.g., ketogenic therapy) within medically supervised frameworks, underscoring that experimental or integrative approaches are layered on top of standard care rather than replacing it.^{[16][17][19][20][22][23]} Mainstream guidance documents and expert reviews on mood and depressive disorders that address CAM emphasize evidence-based use of selected modalities (e.g., exercise, light therapy, omega-3s) primarily for unipolar depression and as first- or second-line options only in mild to moderate major depressive disorder, not as stand-alone treatments for severe conditions like bipolar disorder.^[12]

Mainstream view

The mainstream psychiatric position is that bipolar disorder is a serious, often lifelong mood disorder requiring evidence-based management with mood stabilizers (such as lithium and valproate), atypical antipsychotics, and structured psychosocial interventions, with treatment typically guided by formal clinical practice guidelines and high-quality randomized trials.^[22][23] Complementary or integrative approaches, including specific nutraceuticals and other CAM modalities, may be cautiously considered as adjuncts for some patients under medical supervision, but they are not regarded as replacements for conventional pharmacotherapy, and their evidence base is limited, inconsistent, and of generally lower quality.^{[5][6][7][9][11][16][17][19][20][22]} Naturopathic whole-system treatment of bipolar disorder has only very preliminary, low-level evidence (a small retrospective case series) and is not endorsed in major guidelines as a standard or primary treatment approach.^[8][22][23] Consequently, mainstream practice does not consider naturopathic doctor–led treatment alone to be an evidence-based or sufficient therapy for bipolar disorder, and discontinuation of proven mood-stabilizing medications in favor of naturopathic care is viewed as high risk for relapse and adverse outcomes.^[22][23]

In their own wordsView sourceArchived copy

“bipolar disorder”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Bipolar disorder and schizophrenia

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure Natural Solutions for Depression.

Natural Solutions for Depression

Supports

The claim is very general, but some specific “natural” or complementary interventions have evidence for benefit in depression when used in a structured, evidence‑based way under professional care. Major guidelines for major depressive disorder acknowledge nonpharmacologic treatments such as cognitive‑behavioral therapy (CBT) and other structured psychotherapies as first‑line options, and these can be integrated into care provided by clinicians with various backgrounds, including those who emphasize lifestyle and mind–body approaches.^{[10][12][17][20][23]} Mindfulness‑based cognitive therapy and mindfulness‑based stress reduction are supported by randomized controlled trials showing benefit in depressive symptoms, including in treatment‑resistant or comorbid conditions.^[3][7] Systematic reviews and trials of certain herbal and nutraceutical agents (for example St John’s wort, omega‑3 fatty acids, saffron, lavender) show antidepressant or mood‑improving effects for mild to moderate depression, sometimes comparable to standard antidepressants in short‑term trials, though typically with important caveats about quality, dosing, safety, and interactions.^{[13][18][24][21][15]} Lifestyle interventions such as regular exercise also have evidence for reducing depressive symptoms and are often grouped with “natural” approaches in complementary medicine reviews.^[13] Overall, there is partial support that some natural or complementary strategies can contribute to depression treatment when used in a controlled, evidence‑based, and often adjunctive manner, but this does not equate to broad endorsement of generic “naturopathic treatment” as a replacement for guideline‑directed depression care.

Contradicts

The broad claim that naturopathic doctor treatment or unspecified “natural solutions” are sufficient primary treatment for depression is not supported by high‑quality evidence. Living clinical guidelines from major organizations (e.g., American College of Physicians, national psychiatric bodies) recommend evidence‑based psychotherapies and second‑generation antidepressants as initial treatments for moderate to severe major depressive disorder, with no recommendation to use naturopathic care or generic natural remedies as first‑line monotherapy.^{[10][12][17][20][23]} These guidelines explicitly state that there are no recommendations for St John’s wort or other complementary modalities as primary treatments, reflecting limited or inconsistent evidence and safety concerns.^[12][21] Reviews of complementary and alternative medicine for depression emphasize that although some natural products show promise, the evidence base is heterogeneous, trials are often short‑term and small, and safety and drug–herb interaction data are incomplete; they caution against substituting these approaches for standard care, particularly in moderate to severe or suicidal depression.^[13][18][24] At least one randomized controlled trial of homeopathic treatment for depression failed to show consistent or clinically meaningful benefit compared with placebo, illustrating that not all naturopathic or “natural” modalities are effective even within complementary medicine.^[19] Mainstream depression guidelines also highlight the importance of assessing severity, suicidality, comorbidities, and using treatments with robust RCT and meta‑analytic support; purely naturopathic, non‑evidence‑based regimens fall outside these standards and may delay effective care or pose interaction risks when combined with conventional medications.^{[10][12][17][20][23]}

Mainstream view

Mainstream medical and psychiatric consensus is that major depressive disorder should be managed with evidence‑based treatments whose efficacy and safety are supported by randomized trials, meta‑analyses, and formal clinical guidelines. For mild depression, structured psychotherapies such as CBT or interpersonal therapy are typically recommended, while for moderate to severe depression, either psychotherapy or second‑generation antidepressant pharmacotherapy, or their combination, are first‑line.^{[10][12][17][20][23]} Guidelines increasingly recognize lifestyle measures (exercise, sleep hygiene), some digital and mindfulness‑based interventions, and a limited set of complementary agents (e.g., omega‑3 fatty acids, St John’s wort) as possible adjuncts or, in selected mild cases, alternatives, but emphasize careful attention to product quality, dosing, side‑effect profiles, and drug–herb interactions, and they do not endorse broad naturopathic treatment as a stand‑alone solution.^{[13][18][21][24]} The mainstream position is that “natural” or naturopathic elements can be incorporated within a comprehensive, guideline‑consistent treatment plan, but they should not replace established psychotherapeutic and pharmacologic interventions, especially in moderate to severe or high‑risk depression.

In their own wordsView sourceArchived copy

“Natural Solutions for Depression”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Depression

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to advertise Natural Solutions for Bipolar Disorder as within their scope of practice.

Natural Solutions for Bipolar Disorder

Supports

High-quality evidence supports that certain natural or nutritional interventions can modestly improve specific bipolar symptoms when used as adjuncts to standard mood‑stabilizing and antipsychotic medications, but not as standalone naturopathic cures. ^[9][10] Multiple randomized controlled trials show that omega‑3 polyunsaturated fatty acids (EPA/DHA) can reduce depressive symptoms and some inflammatory markers in bipolar disorder when added to usual treatment, and are generally safe and well tolerated. ^[27][29] Recent RCTs in adults with bipolar disorder report that 2 g/day omega‑3 supplementation for about 2 months decreased depression scores, improved brain‑derived neurotrophic factor, and reduced pro‑inflammatory cytokines compared with placebo. ^[26] Meta‑analyses pooling several RCTs find a statistically significant, moderate effect size for adjunctive omega‑3 on bipolar depressive symptoms, while showing much weaker or absent effects on mania. Some pediatric and high‑risk youth trials suggest that combinations such as omega‑3 plus inositol, or psychoeducation plus omega‑3, may reduce mood symptoms, again as augmentation rather than replacement of standard psychiatric care. Overall, the best available evidence supports certain “natural” agents, especially omega‑3 fatty acids, as adjunctive therapies that can modestly help bipolar depression and possibly relapse prevention, but not as stand‑alone natural solutions capable of fully treating bipolar disorder. ^[28]

Contradicts

Evidence contradicts the idea that naturopathic or natural treatments alone are sufficient or proven to control the full spectrum of bipolar disorder, particularly manic episodes, or to replace guideline‑recommended pharmacologic therapy. ^{[5][8][10][11][27][29]} Systematic reviews and meta‑analyses on omega‑3 fatty acids conclude that while depressive symptoms in bipolar disorder may improve, there is no clear benefit for manic symptoms and overall results are inconsistent or modest, leading authors to state that evidence is insufficient for strong treatment recommendations. ^[26][28] Larger and longer adjunctive omega‑3 prophylaxis trials have failed to show meaningful reductions in episode relapse, hospitalizations, or the need for medication adjustments, indicating that the preventive effect is at best limited. Reviews of complementary and alternative approaches emphasize that data for herbal products and other naturopathic regimens are sparse, often based on small, heterogeneous studies, and do not justify using them in place of mood stabilizers, atypical antipsychotics, and evidence‑based psychotherapy. Major clinical guidelines for bipolar disorder do not endorse naturopathic monotherapy; instead, they highlight the risks of undertreatment, including relapse, suicide, and functional decline, when effective pharmacologic management is delayed or avoided. ^[6][9] Overall, current evidence contradicts claims that bipolar disorder can be adequately treated through naturopathic or natural solutions alone, and shows that such approaches should be considered experimental adjuncts rather than proven primary treatments.

Mainstream view

The mainstream medical and scientific position is that bipolar disorder is a chronic, often serious mood disorder that requires evidence‑based, guideline‑directed management centered on mood‑stabilizing medications (such as lithium, valproate, lamotrigine), atypical antipsychotics, and structured psychotherapies, with careful monitoring for suicidality and relapse. ^{[5][8][10][26][27]} Natural or naturopathic interventions, including omega‑3 fatty acids and certain lifestyle measures (e. ^[28][29] g. , sleep regularity, exercise, avoidance of substances), may be reasonable adjuncts when integrated by clinicians into a comprehensive treatment plan, but they are not considered standalone, primary therapies. ^[9] Major guidelines and expert reviews treat complementary and alternative approaches as optional additions with limited and symptom‑specific evidence, and they emphasize that any use of such therapies should not replace standard pharmacologic treatment, particularly in moderate to severe or recurrent bipolar disorder. ^[6] The mainstream view is therefore that “natural solutions” can play a supportive role but should not be represented as sufficient or proven treatments for bipolar disorder on their own.

In their own wordsView sourceArchived copy

“Natural Solutions for Bipolar Disorder”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Bipolar disorder and schizophrenia

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure Bipolar.

Bipolar

Supports

High-quality evidence for bipolar disorder focuses on conventional pharmacologic and psychosocial treatments (lithium, valproate, antipsychotics, psychotherapy, psychoeducation, adherence interventions), not on naturopathic whole-system care. Recent randomized trials show efficacy of standard agents such as long-acting injectable aripiprazole for maintenance treatment in bipolar I disorder, prolonging time to recurrence of mood episodes compared with placebo, and confirm the central role of mood stabilizers and antipsychotics in mainstream care.^[22][23] Systematic reviews and randomized trials of complementary and alternative medicine identify some nutraceuticals (e.g., omega-3 fatty acids, N-acetylcysteine, certain amino acid drinks, folate) as having modest, inconsistent benefits when used as adjuncts to standard pharmacotherapy, not as stand-alone replacements.^[6][11] Reviews on complementary and alternative medicine in bipolar disorder conclude that integrative use of selected nutrients alongside conventional mood stabilizers and antipsychotics may help bipolar depression or mania in some patients, but emphasize that these are adjunctive and evidence is limited in quality and size.^{[5][6][7][9][11]} A 2019 overview of whole-system, multimodality care reports only a small retrospective case series (n=7) of treatment-resistant bipolar patients receiving naturopathic care for more than one year, with varied outcomes including some mood stabilization and withdrawal of psychotropic medications; as an uncontrolled case series, this is very low-level evidence rather than robust support for efficacy.^[8]

Contradicts

There are no large randomized controlled trials, meta-analyses, or major psychiatric guidelines demonstrating that naturopathic doctor–led treatment alone is effective or safe as a primary therapy for bipolar disorder or as a replacement for mood stabilizers and antipsychotics.^{[5][6][7][9][11][22][23]} The single reported case series of naturopathic management of treatment-resistant bipolar disorder (n=7) is retrospective, uncontrolled, and heterogeneous, offering only anecdotal-level evidence and cannot establish causality or generalizable effectiveness.^[8] Systematic reviews of complementary and alternative therapies in bipolar disorder consistently describe the evidence base as small, methodologically limited, and inconsistent; many nutraceuticals and CAM modalities show no significant benefit over placebo or only weak effects, and are recommended, at most, as adjuncts after first-line conventional treatments rather than as core or sole treatments.^{[5][6][7][9][11]} Recent and ongoing bipolar disorder trials continue to investigate conventional pharmacologic treatments, behavioral adherence interventions, and diet-based protocols (e.g., ketogenic therapy) within medically supervised frameworks, underscoring that experimental or integrative approaches are layered on top of standard care rather than replacing it.^{[16][17][19][20][22][23]} Mainstream guidance documents and expert reviews on mood and depressive disorders that address CAM emphasize evidence-based use of selected modalities (e.g., exercise, light therapy, omega-3s) primarily for unipolar depression and as first- or second-line options only in mild to moderate major depressive disorder, not as stand-alone treatments for severe conditions like bipolar disorder.^[12]

Mainstream view

The mainstream psychiatric position is that bipolar disorder is a serious, often lifelong mood disorder requiring evidence-based management with mood stabilizers (such as lithium and valproate), atypical antipsychotics, and structured psychosocial interventions, with treatment typically guided by formal clinical practice guidelines and high-quality randomized trials.^[22][23] Complementary or integrative approaches, including specific nutraceuticals and other CAM modalities, may be cautiously considered as adjuncts for some patients under medical supervision, but they are not regarded as replacements for conventional pharmacotherapy, and their evidence base is limited, inconsistent, and of generally lower quality.^{[5][6][7][9][11][16][17][19][20][22]} Naturopathic whole-system treatment of bipolar disorder has only very preliminary, low-level evidence (a small retrospective case series) and is not endorsed in major guidelines as a standard or primary treatment approach.^[8][22][23] Consequently, mainstream practice does not consider naturopathic doctor–led treatment alone to be an evidence-based or sufficient therapy for bipolar disorder, and discontinuation of proven mood-stabilizing medications in favor of naturopathic care is viewed as high risk for relapse and adverse outcomes.^[22][23]

In their own wordsView sourceArchived copy

“Bipolar”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Bipolar disorder and schizophrenia

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure For Depression.

For Depression

Supports

The claim is very general, but some specific “natural” or complementary interventions have evidence for benefit in depression when used in a structured, evidence‑based way under professional care. Major guidelines for major depressive disorder acknowledge nonpharmacologic treatments such as cognitive‑behavioral therapy (CBT) and other structured psychotherapies as first‑line options, and these can be integrated into care provided by clinicians with various backgrounds, including those who emphasize lifestyle and mind–body approaches.^{[10][12][17][20][23]} Mindfulness‑based cognitive therapy and mindfulness‑based stress reduction are supported by randomized controlled trials showing benefit in depressive symptoms, including in treatment‑resistant or comorbid conditions.^[3][7] Systematic reviews and trials of certain herbal and nutraceutical agents (for example St John’s wort, omega‑3 fatty acids, saffron, lavender) show antidepressant or mood‑improving effects for mild to moderate depression, sometimes comparable to standard antidepressants in short‑term trials, though typically with important caveats about quality, dosing, safety, and interactions.^{[13][18][24][21][15]} Lifestyle interventions such as regular exercise also have evidence for reducing depressive symptoms and are often grouped with “natural” approaches in complementary medicine reviews.^[13] Overall, there is partial support that some natural or complementary strategies can contribute to depression treatment when used in a controlled, evidence‑based, and often adjunctive manner, but this does not equate to broad endorsement of generic “naturopathic treatment” as a replacement for guideline‑directed depression care.

Contradicts

The broad claim that naturopathic doctor treatment or unspecified “natural solutions” are sufficient primary treatment for depression is not supported by high‑quality evidence. Living clinical guidelines from major organizations (e.g., American College of Physicians, national psychiatric bodies) recommend evidence‑based psychotherapies and second‑generation antidepressants as initial treatments for moderate to severe major depressive disorder, with no recommendation to use naturopathic care or generic natural remedies as first‑line monotherapy.^{[10][12][17][20][23]} These guidelines explicitly state that there are no recommendations for St John’s wort or other complementary modalities as primary treatments, reflecting limited or inconsistent evidence and safety concerns.^[12][21] Reviews of complementary and alternative medicine for depression emphasize that although some natural products show promise, the evidence base is heterogeneous, trials are often short‑term and small, and safety and drug–herb interaction data are incomplete; they caution against substituting these approaches for standard care, particularly in moderate to severe or suicidal depression.^[13][18][24] At least one randomized controlled trial of homeopathic treatment for depression failed to show consistent or clinically meaningful benefit compared with placebo, illustrating that not all naturopathic or “natural” modalities are effective even within complementary medicine.^[19] Mainstream depression guidelines also highlight the importance of assessing severity, suicidality, comorbidities, and using treatments with robust RCT and meta‑analytic support; purely naturopathic, non‑evidence‑based regimens fall outside these standards and may delay effective care or pose interaction risks when combined with conventional medications.^{[10][12][17][20][23]}

Mainstream view

Mainstream medical and psychiatric consensus is that major depressive disorder should be managed with evidence‑based treatments whose efficacy and safety are supported by randomized trials, meta‑analyses, and formal clinical guidelines. For mild depression, structured psychotherapies such as CBT or interpersonal therapy are typically recommended, while for moderate to severe depression, either psychotherapy or second‑generation antidepressant pharmacotherapy, or their combination, are first‑line.^{[10][12][17][20][23]} Guidelines increasingly recognize lifestyle measures (exercise, sleep hygiene), some digital and mindfulness‑based interventions, and a limited set of complementary agents (e.g., omega‑3 fatty acids, St John’s wort) as possible adjuncts or, in selected mild cases, alternatives, but emphasize careful attention to product quality, dosing, side‑effect profiles, and drug–herb interactions, and they do not endorse broad naturopathic treatment as a stand‑alone solution.^{[13][18][21][24]} The mainstream position is that “natural” or naturopathic elements can be incorporated within a comprehensive, guideline‑consistent treatment plan, but they should not replace established psychotherapeutic and pharmacologic interventions, especially in moderate to severe or high‑risk depression.

In their own wordsView sourceArchived copy

“For Depression”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Depression

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure Psychology Today - Depression, Serotonin and the Gut.

Psychology Today - Depression, Serotonin and the Gut

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Psychology Today - Depression, Serotonin and the Gut”

Rule: A.R.S. § 32-1501(28)

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure ADHD/ADD.

ADHD/ADD

Supports

There is no relevant ADHD or naturopathic content in the indexed clinical trial list provided, so none of those papers support the claim that naturopathic doctor treatment is an evidence‑based primary treatment for ADHD/ADD. ^[30][32] Outside this list, some randomized controlled trials and systematic reviews show that specific complementary or “natural” interventions (e. ^[31][33] g. , certain herbal preparations, micronutrients, essential fatty acids) can produce modest improvements in ADHD symptoms or related domains in children when used under controlled conditions. These data suggest that some individual complementary therapies may have limited adjunctive benefit but do not amount to broad validation of naturopathic treatment as a whole for ADHD.

Contradicts

The indexed trials provided are unrelated to ADHD and do not offer any evidence in favor of naturopathic treatment for ADHD/ADD, which indirectly underscores the absence of high‑quality ADHD data in this specific list. More broadly, high‑quality evidence such as network meta‑analyses and recent systematic reviews of ADHD treatments report a lack of robust evidence for most complementary and alternative medicine approaches, including naturopathic modalities, particularly as stand‑alone, first‑line treatments. ^[31][32] These reviews consistently find that established pharmacologic treatments (stimulants and some non‑stimulants) and structured behavioral/psychosocial therapies have substantially stronger and more replicated efficacy than naturopathic or other alternative approaches. Some complementary therapies show mixed or inconclusive results, and several specific natural products have been found ineffective in well‑designed trials, reinforcing that the evidence base for a general claim that “naturopathic doctor treatment of ADHD/ADD” is effective is weak. ^[30]

Mainstream view

Mainstream medical and scientific consensus is that ADHD/ADD is best treated with evidence‑based pharmacologic interventions (primarily stimulant medications, with non‑stimulants as alternatives) combined with behavioral and psychosocial therapies, educational accommodations, and management of comorbidities. Complementary or naturopathic interventions may be considered as adjuncts in selected cases, ideally within an integrative care framework and with careful monitoring, but they are not regarded as first‑line, independently sufficient treatments because their efficacy is generally modest, unreplicated, or uncertain compared with standard therapies. ^[32] Major guidelines therefore do not recommend naturopathic treatment as a primary evidence‑based approach for ADHD/ADD, and emphasize that any use of complementary methods should not replace proven standard care, particularly in moderate to severe ADHD. ^[30][31]

In their own wordsView sourceArchived copy

“ADHD/ADD”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising ADHD

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure Root-Cause Anxiety Framework for Bipolar/Depression.

Root-Cause Anxiety Framework for Bipolar/Depression

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“depression”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Depression

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to advertise reduce the dosage of my benzodiazepine as within their scope of practice.

reduce the dosage of my benzodiazepine

Supports

High-quality guidelines and reviews support the idea that many patients on long-term benzodiazepines should reduce or discontinue them, but only via a gradual, individualized taper under clinical supervision. Major joint guidelines (ASAM and collaborating societies) state that clinicians should regularly reassess the risk–benefit balance of benzodiazepine use and consider tapering when risks outweigh benefits, emphasizing that abrupt discontinuation should be avoided and that dose reductions of roughly 5–10% every 2–4 weeks, not exceeding 25% every 2 weeks, are a reasonable starting framework. ^[34][35] These guidelines were developed using systematic literature review and modified GRADE methodology, qualifying as high-quality evidence. Systematic reviews and meta-analyses on benzodiazepine deprescribing show that gradual tapering, particularly when combined with non-pharmacologic support such as cognitive behavioral therapy and structured deprescribing interventions, significantly improves successful discontinuation compared with usual care or tapering alone. ^[36][37] Narrative and integrative reviews on prolonged benzodiazepine use conclude that long-term use is associated with physiological dependence, withdrawal syndromes, psychomotor impairment, falls, and cognitive deficits, especially in older adults, and therefore support tapering and dose reduction when clinically appropriate. Clinical practice toolkits (e. g. , VA, state-level guidance) also recommend tapering anyone who has been on benzodiazepines beyond short-term use, with stepwise dose reductions and, in some cases, switching to longer-acting agents to facilitate a smoother taper, all reinforcing that dose reduction is an evidence-based goal in many patients.

Contradicts

The evidence does not support a blanket recommendation that every individual should reduce their benzodiazepine dose regardless of clinical context. ^[34][35] Guidelines stress ongoing, individualized risk–benefit assessment and shared decision-making, meaning that in some cases continued treatment at the current dose may be preferable (for example, in severe refractory epilepsy or certain acute psychiatric conditions) and that tapering may not be appropriate or may need to be delayed. ^[37] High-level commentaries and evidence-overview papers emphasize substantial methodological limitations in benzodiazepine tapering research, including heterogeneity of tapering strategies, limited safety data, and a lack of robust patient-centered outcomes, which means that precise, universally optimal taper protocols are not yet firmly established. Some randomized and cluster trials of deprescribing interventions show that structured pharmacist or primary care programs are feasible but may not significantly reduce prescribing or falls over relatively short follow-up, illustrating that changing benzodiazepine use patterns is complex and that dose reduction is not automatically achievable or beneficial in all settings. ^[36] Overall, there is no strong evidence that simply reducing the dose without a plan, monitoring, or supportive interventions is safe; instead, the data highlight risks of withdrawal, relapse of underlying conditions, and the need for careful clinical supervision, thereby contradicting any simplistic or one-size-fits-all claim to “just reduce the dosage” on one’s own.

Mainstream view

The mainstream medical position is that benzodiazepines should generally be used at the lowest effective dose for the shortest duration, and that long-term or high-dose use warrants periodic reassessment with a strong consideration of gradual dose reduction or discontinuation when risks outweigh benefits. ^[36][37] Major multi-society guidelines now explicitly recommend slow, patient-centered tapering rather than abrupt cessation, typically starting with small percentage reductions at intervals of weeks, with flexibility to slow or pause the taper based on symptoms. ^[34][35] Supportive non-pharmacologic treatments, such as cognitive behavioral therapy for insomnia or anxiety and structured deprescribing programs, are recommended to improve success rates and patient comfort. At the same time, mainstream guidance emphasizes that tapering decisions must be individualized: factors such as indication, duration of use, comorbidities, concurrent medications (especially opioids or alcohol), and patient preference all influence whether and how to reduce the dose. Clinicians are advised to avoid sudden self-directed dose reduction or discontinuation, and instead to collaborate with patients on a shared plan that balances potential benefits of lower benzodiazepine exposure against the risks of withdrawal and symptom recurrence.

In their own wordsView sourceArchived copy

“reduce the dosage of my benzodiazepine”

Rule: A.R.S. § 32-1501(28)

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to advertise taken me off of my stomach meds as within their scope of practice.

taken me off of my stomach meds

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“my doctor has taken me off of my stomach meds!”

Rule: A.R.S. § 32-1501(28)

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure End Your Anxiety Forever.

End Your Anxiety Forever

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“The New Holistic Solutions To End Your Anxiety Forever!”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Anxiety

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure Heal Anxiety. Find the Root Cause..

Heal Anxiety. Find the Root Cause.

Supports

The specific claim that anxiety can be healed by finding and treating a single discrete “root cause” is not directly supported by major guidelines or high‑quality trials. ^[6] Anxiety disorders are understood as multifactorial conditions involving genetic vulnerability, neurobiological factors, psychological processes, and environmental stressors, and effective treatment is usually multimodal rather than rooted in a single cause. High‑quality evidence supports structured approaches such as cognitive‑behavioral therapy (CBT), pharmacotherapy (e. ^[11] g. , SSRIs, SNRIs), and lifestyle modifications, but these are not framed as “finding the root cause” in the simplistic sense typically used in influencer content. The index guidelines provided focus on hypertension, nutrition support, inflammatory bowel disease, headache, transfusion, and pericarditis, and demonstrate evidence‑based, guideline‑driven care that integrates multiple risk factors and mechanisms rather than searching for one root cause . ^{[5][7][9][8][17]} GRADE methodology further emphasizes rating quality of evidence and balancing benefits and harms, not attributing complex conditions to a single cause . ^[10]

Contradicts

Mainstream evidence contradicts the idea that anxiety can reliably be “healed” by identifying one underlying root cause. Large bodies of research show that anxiety disorders often have chronic or recurrent courses and require ongoing management, combining psychotherapy, medication, and social or lifestyle interventions. Major guidelines in other conditions (e. ^[6] g. , hypertension, IBD, parenteral nutrition) illustrate that complex disorders are managed through multifactorial risk assessment and stepwise treatment, not by locating a single cause that, once corrected, cures the condition . ^[9] The EFNS guideline for tension-type headache, a condition that frequently coexists with anxiety, similarly describes a multifactorial etiology and recommends symptomatic and preventive therapies rather than rooting treatment in one cause . ^[8] Methodological guidance on rating evidence quality (GRADE) highlights uncertainty and imprecision in clinical research, which is at odds with the overly certain promise that any individual can “heal anxiety” by finding a root cause . ^[10] Overall, high‑quality evidence suggests that while specific triggers or contributing factors (e. g. , trauma, medical conditions, medication effects) can be identified and addressed when present, this does not generalize to a universal root‑cause model or a guaranteed cure for anxiety.

Mainstream view

Mainstream medical and scientific consensus is that anxiety disorders are complex, multifactorial mental health conditions. They arise from an interplay of biology (genetic predisposition, neurochemistry), psychology (cognitive patterns, coping styles), and environment (stress, trauma, social context). Effective management typically involves evidence‑based psychotherapies (especially CBT and related modalities), pharmacologic treatments when indicated, and addressing contributing medical or psychosocial factors. ^[5][9] Clinicians do evaluate for specific contributors such as thyroid disease, substance use, sleep disorders, chronic pain, or major stressors and treat these when found, but this is part of comprehensive assessment rather than a search for a single root cause. Guidelines in other areas, such as hypertension and chronic disease management, reflect this same multifactorial approach and reliance on graded evidence, reinforcing that long‑term conditions are usually managed rather than simply “healed” by correcting one factor . ^[6][10] The mainstream position is that promising a universal ability to heal anxiety by finding one root cause overstates what current evidence supports and may mislead patients away from proven treatments.

In their own wordsView sourceArchived copy

“End Panic. Heal Anxiety. Find the Root Cause.”

Rule: A.R.S. § 32-1501(28)

See every doc bro advertising Anxiety

Nicole Cain is not licensed or approved by Arizona Board of Naturopathic Medicine to diagnose, treat, or cure liver support.

liver support

Supports

High-quality evidence supports certain forms of liver support, primarily lifestyle modification and some specific nutraceuticals, but not a generic “liver support” concept. Multiple guidelines and reviews on nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction–associated fatty liver disease (MASLD) consistently identify weight loss through hypocaloric diet and increased physical activity as the most evidence-based way to improve liver fat, inflammation, and fibrosis.^{[3][4][5][10][15][18]} Structured lifestyle programs (including digital interventions) in MASLD and NAFLD improve liver enzymes, hepatic steatosis, and some fibrosis scores.^{[3][4][5][9][15][18]} A 2025 randomized, double-blind, placebo-controlled trial in healthy adults found that a plant-based nutraceutical combining turmeric, dandelion, milk thistle, and ginger significantly improved liver enzyme profiles versus placebo over 180 days, with no reported adverse events, suggesting hepatoprotective potential in otherwise healthy individuals.^[2][24] Systematic reviews and randomized trials of silymarin (milk thistle) show a modest but possible beneficial effect on liver enzymes and some outcomes in alcoholic liver disease and early alcoholic cirrhosis, with a suggestion of hepatoprotection in toxic liver injury such as Amanita phalloides poisoning.^[6][11][14] A recent systematic review of silymarin RCTs concludes it may ameliorate liver enzyme levels across diverse conditions, with a majority of trials showing reductions in ALT/AST, though not universally.^[6] Curcumin supplementation in MASLD in a 12‑month RCT significantly reduced inflammatory markers, oxidative stress, hepatic steatosis, and liver stiffness compared with placebo, supporting its role as an adjunctive therapy in a defined liver disease population.^[19]

Contradicts

Evidence does not support a broad, unspecified “liver support” claim for most over-the-counter products or detox regimens. Major guidelines for NAFLD/MASLD emphasize lifestyle changes and do not recommend routine use of general liver support supplements, reflecting limited or inconsistent efficacy data.^{[3][4][5][7][8][9][10][15]} Systematic reviews and monographs on milk thistle/silymarin note that clinical efficacy for chronic liver disease is not clearly established, with many trials hampered by poor methodology and heterogeneous outcomes.^[11][12][13] These reviews conclude that evidence for improving viral hepatitis or significantly altering long-term outcomes in chronic liver disease is scarce, and benefits, where present, are modest and restricted to specific contexts like alcoholic Child A cirrhosis or mushroom poisoning rather than general liver health.^[11][12][14] Even in silymarin trials, around one-fifth of studies show no significant change in liver enzymes and a minority show worsening, indicating variable and uncertain benefit.^[6] For healthy individuals, long-term nutraceutical trials are still few; the 180‑day herbal combination trial in healthy adults shows improved enzymes but no demonstrated impact on hard clinical outcomes such as progression to liver disease, so extrapolating to broad “support” claims is premature.^[2][24] Overall, strong RCT and guideline-level data for generic liver detoxes, cleanses, or supplements marketed for “liver support” are lacking, and some may pose risks (e.g., idiosyncratic drug-induced liver injury) not captured in the available trials.

Mainstream view

The mainstream medical position is that the most reliable and evidence-based ways to support liver health are maintaining a healthy weight, following a balanced hypocaloric diet when overweight or obese, limiting or avoiding alcohol, controlling metabolic risk factors, and engaging in regular physical activity.^{[3][4][5][8][9][10][15]} In patients with NAFLD/MASLD, professional society and national guidelines recommend comprehensive lifestyle modification (dietary changes, behavioral strategies, and exercise) as first-line therapy, often aiming for 5–10% weight loss to reduce steatosis and potentially reverse fibrosis.^{[3][4][5][7][9][10][15][18]} Pharmacologic and nutraceutical agents are considered adjuncts or disease-specific therapies rather than general liver support, and their use is typically restricted to defined indications (e.g., resmetirom in NASH with fibrosis, curcumin in MASLD, limited roles for silymarin in specific toxic or alcoholic etiologies).^{[11][14][17][19]} Mainstream practice does not endorse broad, non-specific “liver support” supplements or

In their own wordsView sourceArchived copy

“liver support”

Rule: A.R.S. § 32-1501(28)